Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of Propylene Glycol-Free Melphalan (Evomela) in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Preliminary Results of a Phase II Study

Shayna Sarosiek, John Mark Sloan, MD, Karen Quillen, MDMPH, Dina Brauneis, ANP, Ramon Cruz, Amanda Schulman, Salli Fennessey, Anthony Shelton, Vaishali Sanchorawala, MD

Blood (2019) 134 (Supplement_1): 4578.

https://doi.org/10.1182/blood-2019-129095

Published: 2019

Journal Articles

Novel Role of Raft-Associated Smoothened (SMO) in AKT Signal Regulation in Diffuse Large B Cell Lymphoma

Nitin Agarwal, PhD, Kranthi Kunkalla, Daniel Bilbao, PhD, Ralf Landgraf, PhD, Francisco Vega, MD PhD

Blood (2019) 134 (Supplement_1): 3972.

https://doi.org/10.1182/blood-2019-121847

Published: 2019

Journal Articles

Preclinical Development of an Anti-CD38 Antibody-Drug Conjugate for Treatment of Hematological Malignancies

Lingna Li, PhD, Wenyong Tong, PhD, Megan Lau, BS, Katherine Fells, PhD, Tong Zhu, PhD, Yingqing Sun, PhD, Ernest Kovacs, PhD, Alisher Khasanov, PhD, Zheng Yan, PhD, Dalun Deng, PhD, Ken Takeshita, MD, Gunnar F. Kaufmann, PhD, Henry Ji, PhD, Hui Li, PhD, Hong Zhang, PhD

Blood (2019) 134 (Supplement_1): 5621.

https://doi.org/10.1182/blood-2019-132062

Published: 2019

Journal Articles

Logistical Considerations Related to Melphalan As a Conditioning Agent in Autologous Stem Cell Transplant for Multiple Myeloma: Results of a Survey of Oncology Pharmacists, Nurses and Pharmacy Technicians

Mark Acosta, PharmD, Arrash Darban, PharmD, MS, Matthew Gitlin, PharmD

Blood (2019) 134 (Supplement_1): 5869.

https://doi.org/10.1182/blood-2019-124990

Published: 2019

Journal Articles

Anti-Leukemia Effects of NK Cell-Derived Exosomes

Michael Boyiadzis, MD, Chang Sook Hong, PhD, Theresa L Whiteside, PhD

Blood (2019) 134 (Supplement_1): 3223.

https://doi.org/10.1182/blood-2019-125430

Published: 2019

Journal Articles

Ibrutinib, Venetoclax Plus Obinutuzumab in Newly Diagnosed Mantle Cell Lymphoma Patients

Steven Le Gouill, MD PhD, Franck Morschhauser, MD, Kamal Bouabdallah, MD, Guillaume Cartron, Olivier Casasnovas, MD, Thomas Gastinne, MD, Patrice Chevallier, MD, Cédric Rossi, MD PhD, Emmanuelle Tchernonog, MD, Rory McCulloch, FRCPath, MRCP, MBBS, Charles Herbaux, MD, David Chiron, PhD, Mary Callanan, PhD, Simon Rule

Blood (2019) 134 (Supplement_1): 1530.

https://doi.org/10.1182/blood-2019-125681

Published: 2019

Journal Articles

Engineering CpG Deoxynucleotide-Conjugated Gold Nanoparticles for Enhanced Anti-Lymphoma Effects in an Immune Competent Lymphoma Model

Adam Yuh Lin, MD PhD, Jonathan Rink, PhD, Reem Karmali, MD, Colby Shad Thaxton, MD PhD, Leo I. Gordon, MD

Blood (2019) 134 (Supplement_1): 1577.

https://doi.org/10.1182/blood-2019-125308

Published: 2019

Journal Articles

Novel Thyrointegrin αvβ3 Antagonist for the Treatment of Acute Myeloid Leukemia

Shaker A Mousa, PhD BPharm, MBA, MSc, Thangirala Institute Sudha, PhD, Kavitha Godugu, PhD, Mehdi Rajabi, PhD, Nazeer Tipu, MD, Paul J Davis, MD

Blood (2018) 132 (Supplement 1): 4068.

https://doi.org/10.1182/blood-2018-99-119455

Published: 2018

Journal Articles

Safety and Efficacy of Evomela™ in Myeloma Autotransplants

Kimberly Amelsberg, Nisha Joseph, MD, Amelia Langston, MD, Jonathan L Kaufman, MD, Craig C Hofmeister, MD MPH, Edmund K. Waller, MD, Michael Graiser, PhD, Robin Larocco, Leonard Heffner, MD, Madhav V Dhodapkar, MD, Sagar Lonial, MD, Ajay K Nooka, MD MPH

Blood (2018) 132 (Supplement 1): 3446.

https://doi.org/10.1182/blood-2018-99-119730

Published: 2018

Journal Articles

Evaluation of Clinical Usefulness of Monocyte Gating Using CD14 and CD64 for Detecting PNH Clone By Flow Cytometry

Woo Jae Kwoun, MD, Jeong-Yeal Ahn, MD, Ja Young Seo, MD, Jae Hoon Lee, MD PhD, Hawk Kim, MD PhD, Jinny Park, MD PhD, Kwai Han Yoo, MD, Sung-Ran Cho, MD, Hye Ryoun Kim, MD

Blood (2018) 132 (Supplement 1): 4947.

https://doi.org/10.1182/blood-2018-99-111468

Published: 2018

Journal Articles

Multi-Walled Carbon Nano-Tubes (MWCNTs) Accelerate Leukaemia Development in Mice: Implications for Drug Development in Humans

Bin Yin, PhD, Xiaofeng Han, PhD, Huikai Miao, Min Zhang, Yanwen Zheng, Huiquan Tao, Guangsong Su, Zhengwei Mao, Haiyan Xu, Hongchao Yin, Jiang Hu, Robert Peter Gale, MD ScD, PhD, Fanqing Chen

Blood (2017) 130 (Supplement 1): 5099.

https://doi.org/10.1182/blood.V130.Suppl_1.5099.5099

Published: 2017

Journal Articles

Anti-Pegaspargase, Anti-Calaspargase Pegol , and Anti-Polyethelene Glycol Antibody Incidence in High Risk Acute Lymphoblastic Leukemia Patients Receiving Pegaspargase or Calaspargase Pegol and Associated Anaphylactic or Hypersensitivity Reaction Rates: Results from Children's Oncology Group (COG) Study AALL07P4

Reuven J Schore, MD, Meenakshi Devidas, PhD, Archie Bleyer, MD, Gregory Reaman, MD, Claudia Lebedinsky, MD, Hui Zhang, MS, Herwig Koppensteiner, PhD, Mignon L. Loh, MD, Elizabeth Raetz, MD, Naomi Winick, MD, William L. Carroll, MD, Stephen P. Hunger, MD, Anne Angiolillo, MD

Blood (2016) 128 (22): 3965.

https://doi.org/10.1182/blood.V128.22.3965.3965

Published: 2016

Journal Articles

The Trifunctional Antibody (tri-31C2) Targeting CD38 and CD3 Has a Stronger Anti-Myeloma Effect Than the Chimeric Anti-CD38 Monoclonal Antibody (ch-31C2)

Tadao Ishida, MD PhD, Hiroshi Yasui, MD PhD, Kazuya Ishiguro, MD, Yuka Aoki, MD PhD, Hiroshi Ikeda, MD PhD

Blood (2016) 128 (22): 2097.

https://doi.org/10.1182/blood.V128.22.2097.2097

Published: 2016

Journal Articles

PLGA-PLL-Peg-Tf-Based Targeted Nanoparticles Drug Delivery System Enhance Antitumor Efficacy Via Intrinsic Apoptosis Pathway

Wen Bao, PhD, Ran Liu, PhD, Baoan Chen, PhD Professor, Fei Wang, MD, Haijun Zhang, PhD, Guohua Xia, Xue Wu, MD, Kun Zhao, Xiaoyu Li

Blood (2015) 126 (23): 5558.

https://doi.org/10.1182/blood.V126.23.5558.5558

Published: 2015

Journal Articles

A Phase I Study Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of the Hepcidin Antagonist PRS-080#022. Results from a Randomized, Placebo Controlled, Double-Blind Study Following Single Administration to Healthy Subjects a

Ulrich Moebius, PhD, Werner Feuerer, MD, Edgar Fenzl, MD, Rachel van Swelm, PhD, Dorine W. Swinkels, MD PhD, Andreas Hohlbaum, PhD

Blood (2015) 126 (23): 536.

https://doi.org/10.1182/blood.V126.23.536.536

Published: 2015

Journal Articles

A Phase II Study of MESA Chemotherapy for Newly Diagnosed, Relapsed or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of Northern-West of China

Rong Liang, PhD MD, Gao Guangxun, PhD MD, Chen Jie Ping, PhD MD, Jishi Wang, Xiao min Wang, PhD MD, Yun Zeng, PhD MD, Xie qun Chen, PhD MD, Liang Zhang, MD PhD

Blood (2015) 126 (23): 3945.

https://doi.org/10.1182/blood.V126.23.3945.3945

Published: 2015

Journal Articles

Roneparstat (SST0001), an Innovative Heparanase (HPSE) Inhibitor for Multiple Myeloma (MM) Therapy: First in Man Study

Monica Galli, MD, Hila Magen, MD, Hermann Einsele, Manik Chatterjee, MD, Mariella Grasso, MD, Giorgina Specchia, Paola Barbieri, MD, David Paoletti, MS, Silvia Pace, MS, Ralph D Sanderson, PhD, Alessandro Rambaldi, MD, Arnon Nagler, MD MSc

Blood (2015) 126 (23): 3246.

https://doi.org/10.1182/blood.V126.23.3246.3246

Published: 2015

Journal Articles

Peg-PLGA-PLL Nanoparticles in Combination with Gambogic Acid for Reversing Multidrug Resistance of K562/A02 Cells to Daunorubicin

Peipei Xu, PhD, Ruju Wang, Jian Ouyang, MD, Bing Chen, MD

Blood (2015) 126 (23): 4844.

https://doi.org/10.1182/blood.V126.23.4844.4844

Published: 2015

Journal Articles

Phase II Study of Propylene Glycol-Free Melphalan (Evomela) Combined with Carmustine, Etoposide, and Cytarabine (BEAM) for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

Amanda F. Cashen, MD, Kendall Gosch, BA, Theresa Fletcher, MS, Connie Ceriotti, RN, BSN, Armin Ghobadi, MD, Ravi Vij, MD, Keith Stockerl-Goldstein, MD, John F Dipersio, MD PhD, Camille N Abboud, MD

Blood (2015) 126 (23): 3196.

https://doi.org/10.1182/blood.V126.23.3196.3196

Published: 2015

Journal Articles

Platelet CD36 Induces ERK5 Activation through a Redox-Regulated Signaling Pathway to Promote a Prothrombotic Phenotype

Moua Yang, Jeannette M. Vasquez-Vivar, PhD, Yiliang Chen, PhD, Scott J. Cameron, PhD MD, Craig N. Morrell, DVM, PhD, Roy L. Silverstein, MD

Blood (2015) 126 (23): 1033.

https://doi.org/10.1182/blood.V126.23.1033.1033

Published: 2015

NARROW

Safety and Efficacy of Propylene Glycol-Free Melphalan (Evomela) in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Preliminary Results of a Phase II Study

Novel Role of Raft-Associated Smoothened (SMO) in AKT Signal Regulation in Diffuse Large B Cell Lymphoma

Preclinical Development of an Anti-CD38 Antibody-Drug Conjugate for Treatment of Hematological Malignancies

Logistical Considerations Related to Melphalan As a Conditioning Agent in Autologous Stem Cell Transplant for Multiple Myeloma: Results of a Survey of Oncology Pharmacists, Nurses and Pharmacy Technicians

Anti-Leukemia Effects of NK Cell-Derived Exosomes

Ibrutinib, Venetoclax Plus Obinutuzumab in Newly Diagnosed Mantle Cell Lymphoma Patients

Engineering CpG Deoxynucleotide-Conjugated Gold Nanoparticles for Enhanced Anti-Lymphoma Effects in an Immune Competent Lymphoma Model

Novel Thyrointegrin αvβ3 Antagonist for the Treatment of Acute Myeloid Leukemia

Safety and Efficacy of Evomela™ in Myeloma Autotransplants

Evaluation of Clinical Usefulness of Monocyte Gating Using CD14 and CD64 for Detecting PNH Clone By Flow Cytometry

Multi-Walled Carbon Nano-Tubes (MWCNTs) Accelerate Leukaemia Development in Mice: Implications for Drug Development in Humans

The Trifunctional Antibody (tri-31C2) Targeting CD38 and CD3 Has a Stronger Anti-Myeloma Effect Than the Chimeric Anti-CD38 Monoclonal Antibody (ch-31C2)

PLGA-PLL-Peg-Tf-Based Targeted Nanoparticles Drug Delivery System Enhance Antitumor Efficacy Via Intrinsic Apoptosis Pathway

A Phase I Study Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of the Hepcidin Antagonist PRS-080#022. Results from a Randomized, Placebo Controlled, Double-Blind Study Following Single Administration to Healthy Subjects a

A Phase II Study of MESA Chemotherapy for Newly Diagnosed, Relapsed or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of Northern-West of China

Roneparstat (SST0001), an Innovative Heparanase (HPSE) Inhibitor for Multiple Myeloma (MM) Therapy: First in Man Study

Peg-PLGA-PLL Nanoparticles in Combination with Gambogic Acid for Reversing Multidrug Resistance of K562/A02 Cells to Daunorubicin

Phase II Study of Propylene Glycol-Free Melphalan (Evomela) Combined with Carmustine, Etoposide, and Cytarabine (BEAM) for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

Platelet CD36 Induces ERK5 Activation through a Redox-Regulated Signaling Pathway to Promote a Prothrombotic Phenotype

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only